|
Combining moderate dosage of Bevacizumab with TAS-102 provides longer progression-free time in refractory metastatic colorectal Cancer |
|
|
|
Titel: |
Combining moderate dosage of Bevacizumab with TAS-102 provides longer progression-free time in refractory metastatic colorectal Cancer |
Auteur: |
Tseng, Kuan-Yu Yang, Mu-Ying Chen, Wei-Shone Jiang, Jeng-Kai Wang, Huann-Sheng Chang, Shih-Ching Lan, Yuan-Tzu Lin, Chun-Chi Lin, Hung-Hsin Huang, Sheng-Chieh Cheng, Hou-Hsuan Yang, Yi-Wen Lin, Yu-Zu Chang, Che-Yuan Teng, Hao-Wei |
Verschenen in: |
International journal of colorectal disease |
Paginering: |
Jaargang 39 () nr. 1 pagina's xx |
Jaar: |
2024-12-04 |
Inhoud: |
|
Uitgever: |
Springer Berlin Heidelberg, Berlin/Heidelberg |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|